Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
暂无分享,去创建一个
M C Davies | A. Coombes | M. Davies | S. Davis | J. Watts | M. Vert | L. Illum | L Illum | S S Davis | P. Scholes | M Vert | A G Coombes | P D Scholes | J F Watts | C Ustariz | C. Ustariz | A. Coombes | S. Davis | P.D Scholes | J.F Watts | M. C. Davies
[1] M. Davies,et al. The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process , 1989 .
[2] Robert Gurny,et al. Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .
[3] M. Davies,et al. STATIC SECONDARY ION MASS SPECTROMETRY OF POLYMERIC BIOMATERIALS , 1990 .
[4] N. Oku,et al. Tumor accumulation of novel RES-avoiding liposomes. , 1992, Biochimica et biophysica acta.
[5] R. Müller,et al. Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 , 1993 .
[6] M. Steinhoff,et al. Potential of polymer microencapsulation technology for vaccine innovation. , 1994, Vaccine.
[8] S. Davis,et al. Particle Size Analysis of Colloidal Systems by Photon Correlation Spectroscopy , 1986 .
[9] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[10] D. Briggs. Recent advances in secondary lon mass spectrometry (SIMS) for polymer surface analysis , 1989 .
[11] T Yashiki,et al. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.
[12] S. Davis,et al. The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.
[13] R. Müller,et al. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.
[14] S. Davis,et al. Particle Charge and Surface Hydrophobicity of Colloidal Drug Carriers , 1986 .
[15] D. Grainger,et al. Surface characterization of 2-hydroxyethyl methacrylate/styrene copolymers by angle-dependent X-ray photoelectron spectroscopy and static secondary ion mass spectrometry. , 1992, Journal of biomaterials science. Polymer edition.
[16] M. Davies,et al. The surface characterization of model charged and sterically stabilized polymer colloids by SSIMS and X.p.s. , 1992 .
[17] Sung Chul Yoon,et al. SIMS and XPS studies of polyurethane surfaces 2. Polyurethanes with fluorinated chain extenders , 1987 .
[18] Michel Vert,et al. An XPS and SIMS analysis of biodegradable biomedical polyesters , 1989 .
[19] D. F. Mitchell,et al. X-ray photoelectron spectroscopy and static time-of-flight secondary ion mass spectrometry study of dispersion polymerized polystyrene latexes , 1993 .
[20] F. McLafferty. Interpretation of Mass Spectra , 1966 .
[21] M. Vert,et al. Fate of bioresorbable poly(lactic acid) microbeads implanted in artificial bone defects for cortical bone augmentation in dog mandible. , 1993, Biomaterials.
[22] T M Allen,et al. Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.
[23] S. Davis,et al. Polymeric microspheres as drug carriers. , 1988, Biomaterials.
[24] J. Watts. An introduction to surface analysis by electron spectroscopy , 1990 .
[25] D. Rahman,et al. Biodegradable microparticles as controlled release antigen delivery systems. , 1991, Immunology.
[26] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.
[27] J. Benoit,et al. Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. , 1986, Journal of pharmaceutical sciences.
[28] S. Davis,et al. The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow , 1992, FEBS letters.
[29] T. Epperly,et al. A new long-acting injectable microcapsule system for the administration of progesterone. , 1979, Fertility and sterility.
[30] A. Coombes,et al. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery , 1993 .
[31] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[32] I. Yamakawa,et al. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. , 1992, Journal of pharmaceutical sciences.
[33] M. Davies,et al. The preparation of sub-200 nm biodegradable colloidal particles from poly(β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants , 1994 .